Return
Midterm survival, clinical, and hemodynamic outcomes of a novel mechanical mitral valve prosthesis
DOI:10.1016/j.jtcvs.2024.11.029.png)
Abstract
En 中文
To evaluate the midterm survival, clinical, and hemodynamic outcomes of the On-X mechanical mitral valve, based on the 5-year results of the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT).
Keywords:
mitral valve replacement
mechanical heart valve
prosthetic valve
hemodynamics
survival
BSA
body surface area
CI
confidence interval
INR
international normalized ratio
IRB
Institutional Review Board
MG
mean pressure gradient
MV
mitral valve
MVR
mitral valve replacement
NYHA
New York Heart Association
PROACT
Prospective Randomized On-X Anticoagulation Clinical Trial
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
T
IF:
0
Papers:
507
Citations:
0


